TFFP | tickerfilter.com

Fundamental analysis

25%

Profitability 25%

Dept financing 3%

Liquidity 50%

Performance 25%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

0 0%

1 Month

-79.94%

3 Months

-96.67%

6 Months

-96.70%

1 Year

-99.12%

2 Year

-99.72%

Key data

Stock price

$0.07

P/E Ratio

0.00

DAY RANGE

$0.08 - $2.34

EPS

$0.00

52 WEEK RANGE

$0.09 - $11.00

52 WEEK CHANGE

-$99.02

MARKET CAP

6.967 M

YIELD

N/A

SHARES OUTSTANDING

3.466 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

0.93

PUBLIC FLOAT

AVERAGE 10 VOLUME

N/A

AVERAGE 30 VOLUME

$2,779,752

Company detail

CEO: Glenn R. Mattes
Region: US
Website: tffpharma.com
Employees: 0
IPO year: -

Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company was incorporated in 2018 and is based in Austin, Texas.

TFFP - TFF Pharmaceuticals, Inc.